Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - June 2013

Technology Transfer

26 Jun 2013 - 28 Jun 2013 - London, UK

Bookmark and Share

This three-day interactive workshop is intended to provide an overview of the challenges that must be overcome in transferring manufacturing technology and to highlight some proven techniques for overcoming those challenges.

The focus of the course is on small-molecules and their formulations rather than biological products, although many of the issues faced and techniques discussed will be equally applicable.

Some of the benefits to be derived from this workshop include:

  • An appreciation of where TT fits in the life cycle of a pharmaceutical product.
  • An appreciation of the importance of planning and project management in TT
  • An overview of the potential complexity of technology and product transfer.
  • An outline of proven best practice in technology transfer.
  • An opportunity to discuss current issues and challenges in technology transfer with peers and with an expert faculty.
  • A consideration of 'where next' as we move from traditionally-developed products to a world where products are developed using QbD techniques and controlled by PAT.

Who Should Attend?

Pharmaceutical technologists, Quality Assurance staff, Regulatory staff, Engineering staff, Project Managers and anybody else involved in the transfer of products or technology from one location to another.

Course Programme

Day 1

Why Transfer Technology?

Pharmaceutical Product Life Cycle

  • Development
  • Innovative
  • Mature
  • Generic

Product Transfers and Technology Transfers

  • IP
  • Technology
  • Techniques
  • Regulatory Considerations

Registration Procedures

  • Europe
  • Non-European

Variation Procedures

  • Types of Variations
  • Advantages and Disadvantages

Day 2

Technical Challenges

  • Manufacturing processes
  • Validation
  • Stability
  • Packaging processes

Logistical Challenges

  • Label Changes * Text * Physical
  • Timing * Project Plan * Phase in/out

Day 3

Technical Challenges (2)

Impact of new technology

  •  Quality by Design
  •  Process Analytical Technology

Human Challenges

  • Push versus Pull
  • Team membership and team roles
  • Cross-Cultural Issues
  • Progress Reporting and breaking bad news

Further information
Scientific News
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
World’s First Therapeutic Venom Database
Open-source library describes nearly 43,000 effects on the human body.
Speeding Up the Process of Making Vaccines
System uses a freeze-dry concept to develop "just-add-water" solution.
Surprising Trait Found in Anti-HIV Antibodies
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Single Vaccine for Chikungunya, Related Viruses May be Possible
What if a single vaccine could protect people from infection by many different viruses? That concept is a step closer to reality.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos